The value of Mean Platelet Volume as a prognostic factor in Respiratory Distress Syndrome in premature neonates

Authors

  • Farah ibrahim tishreen university
  • Adnan Dayoub Tishreen University

Abstract

Background: Respiratory Distress Syndrome is a major cause of  morbidity and mortality in premature neonates. MPV is an indicator of platelet  function. It may be considered a risk factor for developing RDS.

Objective: to evaluate the role of Mean Platelet Volume as a prognostic indicator in the occurrence of respiratory distress syndrome in premature infants.

Materials and Methods: An analytical study)case-control) conducted on103 premature:49 males and 54 females, and who were admitted to the Neonatal Intensive Care Department at Tishreen University Hospital between July 2022 and July 2023 after applying exclusion criteria, study sample was divided into two groups: 56.3% of premature infants with RDS and 43.7% premature infants without RDS.  Blood samples were taken on the first and third day of life to conduct complete blood count including (number of platelets and their average size).

Results: the mean of MPV on the first day of life was higher in the RDS group than in the other group with a statistically significant difference. MPV on the third day of life was higher in the RDS group±10.89)1.3(versus±9.21) 1.3) with P:0.0001.                                                                                                                    It was the best cut-off value for MPV on day1 that could be used for prediction RDS is9.9 fl with sensitivity 77.8% and specificity 62.1% respectively. elevation of the mean values of MPV on the first and third days of life increased with increasing severity of RDS. In addition, the mean values of MPV on the first day were higher in the group of premature infants who died(11.84±1.1 versus9.85±1.4, P:0.0001)

Conclusion: : MPV is a simple, readily available biomarker that can be used as an aid to predict RDS incidence.

Downloads

Published

2024-06-06

How to Cite

1.
ابراهيم ف, عدنان ديوب. The value of Mean Platelet Volume as a prognostic factor in Respiratory Distress Syndrome in premature neonates. Tuj-hlth [Internet]. 2024Jun.6 [cited 2024Jun.30];46(2):335-47. Available from: https://journal.tishreen.edu.sy/index.php/hlthscnc/article/view/17102

Issue

Vol. 46 No. 2 (2024): Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

Section

Master student researches

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

 Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series   .  The Readers have the right to send, print and subscribe to the initial version of the article, and the title of  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series  Publisher

journal uses a CC BY-NC-SA license which mean

You are free to:

  • Adapt — remix, transform, and build upon the material
  •  
  • The licensor cannot revoke these freedoms as long as you follow the license terms.

 

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.